QNME · Quanome Technologies, Inc. · Financials
Substantial doubt about the company's ability to continue as a going concern.
“As discussed in Note 2 to the consolidated financial statements, the Company's recurring net losses, negative cash flows from operations and accumulated deficit raised substantial doubt about its ability to continue as a going concern. These factors, among others, raise the substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-K filed Sep 25, 2026
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $5.85M | $2.76M | $18.32M | $12.87M | |
| $2.54M | $1.21M | $14.6M | $10.31M | |
| $3.32M | $1.55M | $3.72M | $2.56M | |
| 56.66% | 56.11% | 20.29% | 19.92% | |
| $5.69M | $2.61M | $4.14M | $2.33M | |
| $85.48K | $53.43K | — | — | |
| $13.51M | $3.04M | $4.24M | $2.32M | |
| -$10.19M | -$1.49M | -$526.04K | $246.9K | |
| -174.21% | -53.95% | -2.87% | 1.92% | |
| $149.66K | $138.99K | $108.01K | $123.6K | |
| $268.71K | $28.12K | — | — | |
| $145.64K | -$196.04K | $230.43K | $761.9K | |
| -$10.05M | -$1.69M | -$295.61K | $1.01M | |
| $91.71K | $212.3K | -$67.34K | $65.07K | |
| -$9.48M | -$5.25M | -$225.25K | $983.6K | |
| -162.1% | -189.91% | -1.23% | 7.64% | |
| — | — | -$3025 | — | |
| -$9.01M | -$5.24M | -$222.04K | $983.36K | |
| USD/shares | -$0.36 | -$0.69 | -$0.04 | $0.16 |
| USD/shares | -$0.36 | -$0.69 | -$0.04 | $0.16 |
| shares | 25.72M | 7.56M | 6M | 6M |
| shares | 25.72M | 7.56M | 6M | 6M |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2025: $853.48K in buybacks.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current portion of convertible debt | 2026-06-30 | USD 85,085 | 10-K filed 2026-09-25 |
| Current portion of loans payable | 2026-06-30 | USD 187,750 | 10-K filed 2026-09-25 |
| Noncurrent loans payable | 2026-06-30 | USD 46,277 | 10-K filed 2026-09-25 |
| Operating lease liabilities | 2026-06-30 | USD 159,236 | 10-K filed 2026-09-25 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 14 similar-size Integrated Freight & Logistics companies (of 31 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Asia | $14,819,977 | $13,081,165 | $5,531,468 |
| United States | $2,970,448 | $5,233,990 | $7,341,423 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Crossborder Airfreights Solutions | $9,246,780 | $10,441,320 | $4,799,206 |
| Cross Border Ocean Freights Solutions | $5,781,180 | $7,873,835 | $8,073,685 |
| Distribution of Pharmaceutical Products | $2,762,465 | — | — |